Spectrum Wealth Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,814
Closed -$246K 39
2022
Q2
$246K Sell
1,814
-298
-14% -$41.1K 0.27% 34
2022
Q1
$315K Sell
2,112
-13,910
-87% -$2.06M 0.3% 36
2021
Q4
$2.6M Buy
16,022
+214
+1% +$34.6K 2.31% 14
2021
Q3
$2.63M Buy
15,808
+64
+0.4% +$10.9K 2.59% 12
2021
Q2
$2.72M Sell
15,744
-5,857
-27% -$967K 2.66% 12
2021
Q1
$3.47M Buy
21,601
+6,616
+44% +$1.13M 3.31% 9
2020
Q4
$2.52M Sell
14,985
-13,615
-48% -$2.21M 2.84% 11
2020
Q3
$4.45M Buy
28,600
+14,652
+105% +$2.4M 2.85% 11
2020
Q2
$2.34M Buy
13,948
+2,239
+19% +$351K 3.3% 9
2020
Q1
$1.52M Sell
11,709
-303
-3% -$43.2K 3.29% 10
2019
Q4
$1.79M Buy
12,012
+621
+5% +$85.3K 3.2% 8
2019
Q3
$1.41M Buy
11,391
+2,045
+22% +$272K 2.8% 13
2019
Q2
$1.3M Buy
+9,346
New +$1.29M 2.67% 13

Other funds holding FBT

Spectrum Wealth Advisory Group's FBT Position: Q3 2022 in Review

Spectrum Wealth Advisory Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 1,814 shares — an estimated $246K sold.

Spectrum Wealth Advisory Group first reported a position in FBT in Q2 2019 and held it in 13 quarters. The position peaked at $4.45M in Q3 2020. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

  • Spectrum Wealth Advisory Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
  • Spectrum Wealth Advisory Group sold 1,814 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $246K.
  • Spectrum Wealth Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and held it in 13 quarters.
  • Spectrum Wealth Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.45M in Q3 2020.
  • 218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Spectrum Wealth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.